Defining the Sensitivity Landscape of 74,389 EGFR Variants to Tyrosine Kinase Inhibitors
bioRxiv(2021)
Abstract
Background Tyrosine kinase inhibitors (TKIs) therapy is a standard treatment for patients with advanced non-small-cell lung carcinoma (NSCLC) when activating epidermal growth factor receptor ( EGFR ) mutations are detected. However, except for the well-studied EGFR mutations, most EGFR mutations lack treatment regimens.
Methods We constructed two EGFR variant libraries containing substitutions, deletions, or insertions using the saturation mutagenesis method. All the variants were located in the EGFR mutation hotspot (exons 18–21). The sensitivity of these variants to afatinib, erlotinib, gefitinib, icotinib, and osimertinib was systematically studied by determining their enrichment in massively parallel cytotoxicity assays using an endogenous EGFR-depleted cell line, PC9.
Results A total of 3,914 and 70,475 variants were detected in the constructed EGFR Substitution-Deletion (Sub-Del) and exon 20 Insertion (Ins) libraries, accounting for 99.3% and 55.8% of the designed variants, respectively. Of the 3,914 Sub-Del variants, 813 were highly enriched in the reversible TKI (erlotinib, gefitinib, icotinib) cytotoxicity assays and 51 were enriched in the irreversible TKI (afatinib, osimertinib) cytotoxicity assays. For the 70,475 Ins variants, insertions at amino acid positions 770–774 were highly enriched in all the five TKI cytotoxicity assays. Moreover, the top 5% of the enriched insertion variants included a glycine or serine insertion at high frequency.
Conclusions We present a comprehensive reference for the sensitivity of EGFR variants to five commonly used TKIs. The approach used here should be applicable to other genes and targeted drugs.
### Competing Interest Statement
The authors have declared no competing interest.
* AA
: Amino acid
Afa
: Afatinib
ATCC
: American Type Culture Collection
CIViC
: Clinical Interpretation of Variants in Cancer
COSMIC
: Catalogue of Somatic Mutations in Cancer
DMS
: Deep mutational scanning
DMSO
: Dimethyl sulfoxide
EGFR
: Epidermal growth factor receptor
EGFR-TKI
: EGFR-tyrosine kinase inhibitor
Erl
: Erlotinib
FACS
: Fluorescent-activated cells sorting
FDR
: False discovery rate
gDNA
: Genomic DNA
Gef
: Gefitinib
Ico
: Icotinib
Ins
: Insertion
MANO
: Mixed-all-nominated-mutants-in-one
MITE
: Mutagenesis by Integrated TilEs
NEB
: New England Biolabs
NSCLC
: Non-small-cell lung carcinoma
Osi
: Osimertinib
sgRNA
: Single guide RNA
STR
: Short tandem repeat
Sub-Del
: Substitution-Deletion
TKI
: Tyrosine kinase inhibitor
VUS
: Variants of unknown significance
MoreTranslated text
Key words
egfr variants,tyrosine kinase inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined